Devices for ex vivo heart and lung perfusion

References

• Meachery G, De Soyza A, Nicholson A, et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax. 2008;63:725–731.
   PubMed Web of Science ®Google Scholar
• Punch J, Hayes D, Laporte H, et al. Organ donation and utilization in the United States, 1996–2005. Am J Transplant. 2007;7:1327–1338.
   PubMed Web of Science ®Google Scholar
• Ford M, Almond C, Gauvreau K, et al. Association of graft ischemic time with survival after heart transplant among children in the United States. J Hear Lung Transplant. 2011;30:1244–1249.
   PubMed Web of Science ®Google Scholar
• Sommer W, Kuhn C, Tudorache I, et al. Extended criteria donor lungs and clinical outcome: results of an alternative allocation algorithm. J Hear Lung Transplant. 2013;32:1065–1072.
   PubMed Web of Science ®Google Scholar
• Carrel A, Lindbergh CA. THE CULTURE OF WHOLE ORGANS. Science. 1935;81:621–623.
   PubMedGoogle Scholar
• Makdisi G, Makdisi T, Jarmi T, et al. Ex vivo lung perfusion review of a revolutionary technology. Ann Transl Med. 2017;5:343–350.
   PubMed Web of Science ®Google Scholar
• Schmack B, Weyman A, Mohite P, et al. Contemporary review of the organ care system in lung transplantation: potential advantages of a portable ex-vivo lung perfusion system. Expert Rev Med Devices. 2016;13:1035–1041.
   PubMed Web of Science ®Google Scholar
• Munshi L, Keshavjee S, Cypel M. Donor management and lung preservation for lung transplantation. Lancet Respir Med. 2013;1:318–328.
   PubMed Web of Science ®Google Scholar
• Hardesty R, Griffith B. Autoperfusion of the heart and lungs for preservation during distant procurement. J Thorac Cardiovasc Surg. 1987;93:11–18.
   PubMed Web of Science ®Google Scholar
• Van Raemdonck D, Neyrinck A, Cypel M, et al. Ex-vivo lung perfusion. Transpl Int. 2015;28:643–656.
   PubMed Web of Science ®Google Scholar
• Steen S, Sjiberg T, Pierre L, et al. Transplantation of lungs from non-neart-beating donnor. Lancet. 2001;356:825–829.
   Google Scholar
• Sage E, De Wolf J, Puyo P, et al. Real-Time computed tomography highlights pulmonary parenchymal evolution during Ex Vivo lung reconditioning. Ann Thorac Surg. 2013;103:e535–e537.
   Google Scholar
• Cypel M, Yeung J, Liu M, et al. Normothermic Ex Vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;364:1431–1440.
   PubMed Web of Science ®Google Scholar
• Cypel M, Keshavjee S. Ex Vivo lung perfusion. oper. tech. thorac. cardiovasc. surg. A comp. Atlas. 2014;19:433–442.
   Google Scholar
• Zeriouh M, Sabashnikov P, Mohite P, et al. Utilization of the organ care system for bilateral lung transplantation: preliminary results of a comparative study. Interact Cardiovasc Thorac Surg. 2016;23:351–357.
   PubMed Web of Science ®Google Scholar
• Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the organ care system lung before bilateral transplantation: A pilot study of 12 patients. Lancet. 2012;380:1851–1858.
   PubMed Web of Science ®Google Scholar
• Wauwer C, Munneke A, Engels G, et al. In situ lung perfusion is a valuable tool to assess lungs from donation after circulatory death donors category I – II. Transpl Int. 2013;26:485–492.
   PubMed Web of Science ®Google Scholar
• Sanchez P, Mackowick K, Kon Z. Current state of ex-vivo lung perfusion. Curr Opin Organ Transplant. 2016;21:258–266.
   PubMed Web of Science ®Google Scholar
• Cypel M, Yeung J, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg. 2012;144:1200–1207.
   PubMed Web of Science ®Google Scholar
• Roman M, Nair S, Tsui S, et al. Comparison between cellular and acellular perfusates for ex vivo lung perfusion in a porcine model. J Hear Lung Transplant. 2015;34:978–987.
   PubMed Web of Science ®Google Scholar
• Linacre V, Cypel M, Machuca T, et al. Importance of left atrial pressure during ex vivo lung perfusion. J Hear Lung Transplant. 2016;35:808–814.
   PubMed Web of Science ®Google Scholar
• Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic Ex Vivo lung perfusion. J Hear Lung Transplant. 2008;27:1319–1325.
   PubMed Web of Science ®Google Scholar
• Hsin M, Iskender I, Nakajima D, et al. Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion. J Hear Lung Transplant. 2016;35:130–136.
   PubMed Web of Science ®Google Scholar
• Lindstedt S, Eyjolfsson A, Koul B, et al. How to recondition Ex Vivo initially rejected donor lungs for clinical transplantation: clinical experience from Lund University Hospital. J Transplant. 2011;2011:1–7.
   Google Scholar
• Andreasson A, Borthwick L, Gillespie C, et al. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion. J Hear Lung Transplant. 2017;36:1–11.
   PubMed Web of Science ®Google Scholar
• Nakajima D, Cypel M, Bonato R, et al. Ex vivo perfusion treatment of infection in human donor lungs. Am J Transplant. 2016;16:1229–1237.
   PubMed Web of Science ®Google Scholar
• Andreasson A, Karamanou J, Perry J, et al. The effect of ex vivo lung perfusion on microbial load in human donor lungs. J Hear Lung Transplant. 2014;33:910–916.
   PubMed Web of Science ®Google Scholar
• Machuca T, Hsin M, Ott H, et al. Injury-specific ex vivo treatment of the donor lung: pulmonary thrombolysis followed by successful lung transplantation. Am J Respir Crit Care Med. 2013;188:878–880.
   PubMed Web of Science ®Google Scholar
• Inci I, Yamada Y, Hillinger S, et al. Successful lung transplantation after donor lung reconditioning with urokinase in Ex vivo lung perfusion system. Ann Thorac Surg. 2014;98:1837–1838.
   PubMed Web of Science ®Google Scholar
• Luc J, Bozso S, Freed D, et al. Successful repair of donation after circulatory death lungs with large pulmonary embolus using the lung organ care system for ex vivo thrombolysis and subsequent clinical transplantation. Transplantation. 2015;99:e1–2.
   PubMed Web of Science ®Google Scholar
• Lindstedt S, Liersch-Nordqvist A, Pierre L, et al. The impact of heparin and alteplase on pulmonary graft function in donation after cardiac death-an experimental study. Am J Transplant. 2016;16:84–90.
   Web of Science ®Google Scholar
• Emaminia A, Lapar D, Zhao Y, et al. Adenosine A2A agonist improves lung function during Ex vivo lung perfusion. Ann Thorac Surg. 2011;92:1840–1846.
   PubMed Web of Science ®Google Scholar
• Wagner C, Pope N, Charles E, et al. Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death. J Thorac Cardiovasc Surg. 2016;151:538–545.
   PubMed Web of Science ®Google Scholar
• Kondo T, Chen F, Ohsumi A, et al. β2-adrenoreceptor agonist inhalation during ex vivo lung perfusion attenuates lung injury. Ann Thorac Surg. 2015;100:480–486.
   PubMed Web of Science ®Google Scholar
• Bozso S, Vasanthan V, Luc J, et al. Lung transplantation from donors after circulatory death using portable ex vivo lung perfusion. Can Respir J. 2014;22:47–51.
   PubMed Web of Science ®Google Scholar
• Hopkins P, Chambers D, Naidoo R, et al. Australia’s experience with ex-vivo lung perfusion of highly marginal donors. J Hear Lung Transplant. 2013;32:S154.
   Web of Science ®Google Scholar
• Machuca T, Mercier O, Collaud S, et al. Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion. Am J Transplant. 2015;15:993–1002.
   PubMed Web of Science ®Google Scholar
• Wallinder A, Riise G, Ricksten S, et al. Transplantation after ex vivo lung perfusion: A midterm follow-up. J Hear Lung Transplant. 2016;35:1303–1310.
   PubMed Web of Science ®Google Scholar
• Sanchez P, Mackowick K, Kon Z. The NOVEL lung trial one-year outcomes. J Hear Lung Transplant. 2014;33:S71–S72.
   PubMed Web of Science ®Google Scholar
• Cypel M, Levvery B, Van Raemdonck D, et al. International society for heart and lung transplantation donation after circulatory death registry report. J Hear Lung Transplant. 2015;34:1278–1282.
   PubMed Web of Science ®Google Scholar
• Kootstra G, Daemen J, Oomen A. Categories of non-heart-beating donors. Transplant Proc. 1995;27:2893–2894.
   PubMed Web of Science ®Google Scholar
• Moradiellos F, Naranjo M, Cordoba M, et al. Clinical lung transplantation after ex vivo evaluation of uncontrolled non heart-beating donors lungs: initial experience. J Hear Lung Transplant. 2011;30:2011.
   Web of Science ®Google Scholar
• Orens J, Boehler A, De Perrot M, et al. A review of lung transplant donor acceptability criteria. J Hear Lung Transplant. 2003;22:1183–1200.
   PubMed Web of Science ®Google Scholar
• Meers C, Van Raemdonck D, Verleden GM, et al. The number of lung transplants can be safely doubled using extended criteria donors; A single-center review. Transpl Int. 2010;23:628–635.
   PubMed Web of Science ®Google Scholar
• Wierup P, Haraldsson A, Nilsson F, et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg. 2006;81:460–466.
   PubMed Web of Science ®Google Scholar
• Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83:2191–2194.
   PubMed Web of Science ®Google Scholar
• Tikkanen J, Cypel M, Machuca TN, et al. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation. J Hear Lung Transplant. 2014;34:1–10.
   PubMed Web of Science ®Google Scholar
• Kobashigawa J, Zuckerman A, Macdonald P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Hear Lung Transplant. 2014;33:327–340.
   PubMed Web of Science ®Google Scholar
• Stehlik J, Edwards L, Kucheryavaya A, et al. The registry of the international society for heart and lung transplantation: 29th official adult heart transplant report—2012. J Hear Lung Transplant. 2012;31:1052–1064.
   PubMed Web of Science ®Google Scholar
• Cobert M, Peltz M, West L, et al. Maintenance of human heart oxidative metabolism after 12 hour perfusion preservation. J Hear Lung Transplant Abstr. 2009;28:S126.
   Web of Science ®Google Scholar
• Collins M, Moainie S, Griffith B, et al. Preserving and evaluating hearts with ex vivo machine perfusion: an avenue to improve early graft performance and expand the donor pool. Eur J Cardiothorac Surg. 2008;34:318–325.
   PubMed Web of Science ®Google Scholar
• Skrzypiec-Spring M, Grotthus B, Szelag A, et al. Isolated heart perfusion according to Langendorff-Still viable in the new millennium. J Pharmacol Toxicol Methods. 2007;55:113–126.
   PubMedGoogle Scholar
• Messer S, Ardehali A, Tsui S. Normothermic donor heart perfusion: current clinical experience and the future. Transpl Int. 2015;28:634–642.
   PubMed Web of Science ®Google Scholar
• White C, Hasanally D, Mundt P, et al. A whole blood-based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion. J Heart Lung Transplant. 2015;34:113–121.
   PubMed Web of Science ®Google Scholar
• Macdonald P, Chew H, Connellan M, et al. Extracorporeal heart perfusion before heart transplantation. Curr Opin Organ Transplant. 2016;21:336–342.
   PubMed Web of Science ®Google Scholar
• Stamp N, Shah A, Vincent V, et al. Successful heart transplant after ten hours out-of-body time using the transmedics organ care system. Hear Lung Circ. 2015;24:611–613.
   PubMed Web of Science ®Google Scholar
• Weymann A. Utilization of the organ care system – a game-changer in combating donor organ shortage. Med Sci Monit Basic Res. 2015;21:29–32.
   PubMed Web of Science ®Google Scholar
• Hamed A, Tsui S, Huber J, et al. Serum lactate is a highly sensitive and specific predictor of post cardiac transplant outcomes using the organ Care system. J Hear Lung Transplant. 2009;28:S71.
   Web of Science ®Google Scholar
• Ghodsizad A, Bordel V, Ungerer M, et al. Ex vivo coronary angiography of a donor heart in the organ care system. Heart Surg Forum. 2012;15:161.
   Web of Science ®Google Scholar
• Hassanein A, Elbatanony A, Abdelaziem A, et al. The Organ Care System (OCS) enables ex-vivo assessment of donor heart coronary perfusion using contrast echocardiography. J Hear Lung Transplant. 2009;28:S150.
   Web of Science ®Google Scholar
• Ardehali A, Esmailian F, Deng M, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): A prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;386:2577–2584.
   Google Scholar
• Iyer A, Gao L, Doyle A, et al. Normothermic ex vivo perfusion provides superior organ preservation and enables viability assessment of hearts from DCD donors. Am J Transpl. 2015;15:371–380.
   PubMed Web of Science ®Google Scholar
• Van Raemdonck D, Neyrinck A, Rega F, et al. J. Machine perfusion in organ transplantation. Curr Opin Organ Transplant. 2013;18:24–33.
   PubMed Web of Science ®Google Scholar
• García Sáez D, Zych B, Sabashnikiv A, et al. Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. Ann Thorac Surg. 2014;98:2099–2106.
   PubMed Web of Science ®Google Scholar
• Barnard C. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital. Cape Town S Afr Med J. 1967;41:1271–1274.
   PubMedGoogle Scholar
• Longnus S. Heart transplantation with donation after circulatory determination of death. Nat Rev Cardiol. 2014;11:354–363.
   PubMed Web of Science ®Google Scholar
• Hassanein W, Zellos L, Tyrrell T, et al. Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function. J Thorac Cardiovasc Surg. 1998;116:821–830.
   PubMed Web of Science ®Google Scholar
• Steffen R, Miletec K, Schraufnagel D, et al. Mechanical circulatory support in pediatrics. Expert Rev Med Devices. 2014;13:507–514.
   Web of Science ®Google Scholar
• Boucek M, Mashburn C, Dunn S, et al. Pediatric heart transplantation after declaration of cardiocirculatory death. N Engl J Med. 2008;7:709–714.
   Google Scholar
• Southerland K, Castleberry A, Williams J, et al. Impact of donor cardiac arrest on heart transplantation. Surg. 2013;154:312–319.
   PubMed Web of Science ®Google Scholar
• Ali A, Lim E, Thanikachalam M, et al. Cardiac arrest in the organ donor does not negatively influence recipient survival after heart transplantation. Eur J Cardiothorac Surg. 2007;31:929–933.
   PubMed Web of Science ®Google Scholar
• Dhital K, Iyer A, Connellan M, et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: A case series. Lancet. 2015;385:2585–2591.
   PubMed Web of Science ®Google Scholar
• Chan J, Kobashigawa J, Reich H, et al. Intermediate outcomes with ex-vivo allograft perfusion for heart transplantation. J Hear Lung Transplant. 2017;36:258–263.
   PubMed Web of Science ®Google Scholar
• Christie J, Edwards L, Kucheryavaya A, et al. The registry of the international society for heart and lung transplantation: twenty-seventh official adult lung and heart-lung transplant report2010. J Heart Lung Transplant. 2010;29:1104–1118.
   PubMed Web of Science ®Google Scholar
• Koerner M, Ghodsizad A, Schulz U, et al. Normothermic ex vivo allograft blood perfusion in clinical heart transplantation. Heart Surg Forum. 2014;17:141–145.
   Web of Science ®Google Scholar
• Roman M, Nair S, Tsui S, et al. Ex vivo lung perfusion. Transplant J. 2013;96:509–518.
   PubMed Web of Science ®Google Scholar
• Tane S, Noda K, Shigemura N. Ex vivo lung perfusion: a key tool for translational science in the lungs. Chest. 2017;151:1220–1228.
   PubMed Web of Science ®Google Scholar
• Martens A, Van Raemdonck D, Smits J, et al. A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors. Transpl Int. 2017;30:1002–1010.
   PubMed Web of Science ®Google Scholar
• Briot R, Gennai S, Maignan M, et al. Ex vivo lung graft perfusion. Anaesth Crit Care Pain Med. 2016;35:123.
   PubMed Web of Science ®Google Scholar
• Loor G, Warnecke G, Smith M, et al. The OCS lung EXPAND international trial interim results. J Hear Lung Transplant. 2016;35:S68–S69.
   Web of Science ®Google Scholar